The British Minister of Health noted in an interview that in the study of the University of Oxford and the company Astrazenka more than 30 million doses have already been produced • "I am optimistic", he said
"Corona vaccine - early 2021"
Photo:
AP - Archive
Hope in the race for the vaccine?
In an interview with LBC radio station, British Health Minister Matt Hancock said today (Monday) that the vaccine being developed by the University of Oxford in London and the pharmaceutical company Astrazenka will be implemented "in the first months of 2021."
He said the developers' initial expectation was the end of the current civil year, but various delays have delayed mass production for next year.
"We have already produced more than 30 million vaccine doses that are sufficient to vaccinate about half of the British population," the minister said, noting that investigators are awaiting approval from Health Ministry inspectors.
"In fact, the development has already begun after receiving the approval, so that we can start mass production right upon receipt."
The British health minister added that the first to receive the vaccine upon receipt of the permit would be first-line workers - hospitals, ambulance drivers and emergency crews - as well as people at risk with background illnesses, elderly people living in their homes and citizens living in nursing homes.
Meanwhile, the efficacy of the co-vaccine has not yet been proven, but the initial results were very promising and showed that the development is safe for use in humans.
In addition, the participants in the trial did not develop any side effects and developed an immune response.
In the third phase of the joint study, more than 50,000 people around the world are taking part, and the vaccine is given to different people to test whether it prevents them from becoming infected in the community in which they live.
